These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26379984)
21. Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab. Shiono A; Kogo J; Sasaki H; Yomoda R; Jujo T; Tokuda N; Kitaoka Y; Takagi H PLoS One; 2018; 13(6):e0199552. PubMed ID: 29924853 [TBL] [Abstract][Full Text] [Related]
22. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Kang HM; Koh HJ Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069 [TBL] [Abstract][Full Text] [Related]
23. Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD. Waizel M; Todorova MG; Masyk M; Wolf K; Rickmann A; Helaiwa K; Blanke BR; Szurman P BMC Ophthalmol; 2017 May; 17(1):79. PubMed ID: 28535756 [TBL] [Abstract][Full Text] [Related]
24. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Pichi F; Morara M; Torrazza C; Manzi G; Alkabes M; Balducci N; Vitale L; Lembo A; Ciardella AP; Nucci P Am J Ophthalmol; 2013 Feb; 155(2):287-294.e1. PubMed ID: 23111179 [TBL] [Abstract][Full Text] [Related]
25. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients. Yang X; Dai H Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225 [TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Parodi MB; Iacono P; Menchini F; Sheth S; Polini G; Pittino R; Bandello F Acta Ophthalmol; 2013 May; 91(3):267-73. PubMed ID: 21951313 [TBL] [Abstract][Full Text] [Related]
27. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment. Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605 [TBL] [Abstract][Full Text] [Related]
28. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion. Bayat AH; Çakır A; Özturan ŞG; Bölükbaşı S; Erden B; Elçioğlu MN Int J Ophthalmol; 2018; 11(9):1534-1538. PubMed ID: 30225230 [TBL] [Abstract][Full Text] [Related]
29. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
31. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study. Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038 [TBL] [Abstract][Full Text] [Related]
32. Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography. Kim H; Lee SC; Kim SM; Lee JH; Koh HJ; Kim SS; Byeon SH; Kim M; Lee CS Ophthalmologica; 2015; 233(3-4):146-54. PubMed ID: 25833061 [TBL] [Abstract][Full Text] [Related]
33. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor. Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037 [TBL] [Abstract][Full Text] [Related]
34. Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab. Massamba N; Dirani A; Knoeri J; Pasquier B; Ingram A; Soubrane G Eye (Lond); 2015 Nov; 29(11):1453-7. PubMed ID: 26206530 [TBL] [Abstract][Full Text] [Related]
35. Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab. Calvo P; Ferreras A; Al Adel F; Wang Y; Brent MH Br J Ophthalmol; 2015 Jun; 99(6):723-6. PubMed ID: 25425713 [TBL] [Abstract][Full Text] [Related]